Page 28 - IMCJ April 2020

14. Berglund L, Brunzell J, et al. Evaluation and treatment of hypertriglyceridemia:
Conclusion an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab.
Fasting elevated triglycerides are a serious marker for 2012;97(9):2969-89.
arthrogenic potential especially when associated with a 15. Jagla A, Schrezenmeir J. Postprandial triglycerides and endothelial function.
Exp Clin Endocrinol Diabetes. 2001;109(4):S533-47.
low HDL 50. Indeed the triglyceride/HDL ratio has 16. Nordestgaard B, Benn M, et al. Nonfasting triglycerides and risk of myocardial
considerable merit in the assessment of cardiovascular infarction, ischemic heart disease, and death in men and women. JAMA 2007;
298:299–308.
risk. Higher ratios >3.5 should be modified. Ideal ratio < 17. Goldberg I, Eckel R, et al. Triglycerides and heart disease: still a hypothesis?.
2 should be strived for. This twelve week trial using spore Arterioscler Thromb Vasc Biol. 2011;31(8):1716-25.
forming bacilli probiotics have remarkable triglyceride 18. Carr A, Samaras K, et al. Pathogenesis of hiv-1-protease inhibitor-associated
peripheral lipodystrophy, hyperlipidaemia, and insulin resistance. Lancet.
lowering. The cardiovascular implications of this study 1998;351:1881–1883.
are intriguing especially when we consider the profound 19. Anuurad E, Bremer A, et al. Hiv protease inhibitors and obesity. Current
opinion in endocrinology, diabetes, and obesity. 2010;17:478–485.
impact of lowering triglycerides in the prevention of 20. Hakeam H, Al-Jedai A, et al. Sirolimus induced dyslipidemia in tacrolimus
coronary artery events. For example, in patients with based vs. Tacrolimus free immunosuppressive regimens in renal transplant
recipients. Annals of transplantation : quarterly of the Polish Transplantation
acute coronary syndrome, treated effectively with statins, Society. 2008;13:46–53.
triglycerides appear to be another important target for 21. Kronenberg F. Dyslipidemia and nephrotic syndrome: Recent advances.
subsequent therapy. 51,52 Journal of renal nutrition: the official journal of the Council on Renal Nutrition
of the National Kidney Foundation. 2005;15:195–203.
Elevated triglyceride–rich lipoproteins must be 22. Kaysen G. Lipid and lipoprotein metabolism in chronic kidney disease.
addressed in attenuating cardiovascular risk. The Journal of renal nutrition: the official journal of the Council on Renal Nutrition
of the National Kidney Foundation. 2009;19:73–77.
utilization of probiotics as demonstrated in this analysis 23. Zilversmit D. Atherogenic nature of triglycerides, postprandial lipidemia, and
triglyceride-rich remnant lipoproteins. Clin Chem 1995;41:153–158.
should strongly be considered. 24. Bansal S, Buring J, et al. Fasting compared with nonfasting triglycerides and
Although omega 3s, weight reduction, dietary risk of cardiovascular events in women. JAMA 2007; 298:309–316.
restriction of carbohydrates, exercise, and statins are 25. Havel R, Kane J. Introduction: structure and metabolism of plasma
important concepts in supporting acceptable triglyceride lipoproteins. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The
Metabolic and Molecular Bases of Inherited Disease. 7. New York, NY:
levels, the initiation of targeted probiotics is yet another McGraw-Hill; 1995. pp. 1841–1851.
simple and easy intervention in attenuating cardiovascular 26. Marcoux C, Hopkins P, et al. Remnant-like particle cholesterol and triglyceride
levels of hypertriglyceridemic patients in the fed and fasted state. J Lipid Res.
risk. 2000;41:1428–1436.
27. Patsch J, Miesenbock G,et al. Relation of triglyceride metabolism and
coronary artery disease. Studies in the postprandial state. Arterioscler Thromb.
Limitation 1992;12:1336–1345.
Larger groups of participants in a double-blinded 28. Gryn, S, Hegele R, et al. Novel therapeutics in hypertriglyceridemia. Current
Opinion in Lipidology, Issue: Volume 26(6), December 2015, p 484–491.
placebo-controlled study would give more data in order to 29. Canner P, Berge K, et al. Fifteen year mortality in Coronary Drug Project
fully determine the effects of spore forming bacilli patients: long- term benefit with niacin. J Am Coll Cardiol 1986; 8:1245–1255.
probiotics on HT. In a similar manner, more data should 30. Boden W, Probstfield J, et al. Aim-High Investigators: Niacin in patients with
low HDL cholesterol levels receiving intensive statin therapy. N Engl J Med
be obtained with fasting trigclycerides in participants to 2011; 365:2255–2267.
establish what effects, if any, would spore forming bacilli 31. Landray M, Haynes R, et al. Hps Thrive Collaborative Group Effects of
extended-release niacin with laropiprant in high-risk patients. N Engl J Med
probiotics have on HT. 2014; 371:203–212.
32. Hegele R, Ginsberg H, et al. The polygenic nature of hypertriglyceridaemia:
implications for definition, diagnosis, and management. Lancet Diabetes
References Endocrinol 2013;2:655–666.
1. Berglund L, Brunzell J, et al. Treatment options for hypertriglyceridemia: from 33. Elshaghabee F, Rokana N. et al. “Bacillus As Potential Probiotics: Status,
risk reduction to pancreatitis. Best Pract Res Clin Endocrinol Metab. Concerns, and Future Perspectives” Frontiers in microbiology vol. 8 1490;Aug.
2013;28(3):423-37. 2017.
2. Libby P. Triglycerides on the rise: should we swap seats on the seesaw?. Eur 34. FAO/WHO (2001). Health and Nutritional Properties of Probiotics in Food
Heart J. 2014;36(13):774-6. Including Powder Milk With Live Lactic Acid Bacteria. Report of a joint FAO/
3. Tenenbaum A, Klempfner R, et al. Hypertriglyceridemia: a too long unfairly WHO expert consultation on evaluation of health and nutritional properties
neglected major cardiovascular risk factor. Cardiovasc Diabetol. 2014;13:159. of probiotics in food including powder milk with live lactic acid bacteria
4. Pramono L, Harbuwono D. Managing Hypertriglyceridemia in Daily Practice. Rome: Food and Agriculture Organization.
Acta Med Indones. 2015 Jul;47(3):265-71. 35. Wang J, Tang H., et al. Modulation of gut microbiota during probiotic-
5. Jagla A, Schrezenmeir J. Postprandial triglycerides and endothelial function. mediated attenuation of metabolic syndrome in high fat diet-fed mice. ISME
Exp Clin Endocrinol Diabetes. 2001;109(4):S533-47. 2015; J. 9 1–15.
6. Welty F. How do elevated triglycerides and low HDL-cholesterol affect 36. Bader J., Albin A, et al. Spore-forming bacteria and their utilisation as
inflammation and atherothrombosis? Curr Cardiol Rep. 2013;15(9):400. probiotics. Benef. Microbes 2012; 3 67–75.
7. Sarwar N, Danesh J, et al. Triglycerides and the risk of coronary heart disease: 37. Campbell, AW. Inflammation and a Solution: Probiotics. Altern Ther Health
10,158 incident cases among 262,525 participants in 29 Western prospective Med. 2016; 22(5):8-12.
studies. Circulation 2007;115:450–458. 38. Lefevre M, Racedo S, et al. Probiotic strain Bacillus subtilis CU1 stimulates
8. Sarwar N, Sandhu M, et al. Triglyceride-mediated pathways and coronary immune system of elderly during common infectious disease period: a
disease: collaborative analysis of 101 studies. Lancet 2010;375:1634–1639. randomized, double-blind placebo-controlled study. Immun. Ageing 2015; 12
9. Albrink M, Man E. Serum triglycerides in coronary artery disease. AMA Arch 24.
Intern Med. 1959;103:4–8. 39. Shobharani P, Padmaja R, et al. Diversity in the antibacterial potential of
10. Castelli W. The triglyceride issue: a view from Framingham. Am Heart J. probiotic cultures Bacillus licheniformis MCC2514 and Bacillus licheniformis
1986;112:432–437. MCC2512. Res. Microbiol. 2015; 166 546–554.
11. LaRosa J. Triglycerides and coronary risk in women and the elderly. Arch 40. Ripert G, Racedo S, et al. Secreted compounds of the probiotic Bacillus clausii
Intern Med. 1997;157:961–968. strain O/C inhibit the cytotoxic effects induced by Clostridium difficile and
12. Robert C, Lanier I. Management of hypertriglyceridemia. Am Fam Physician. Bacillus cereus toxins. Antimicrob. Agents Chemother 2016; 60 3445–3454.
2007;75:1365-71. 41. Fakhry S, Sorrentini I, et al. Characterization of spore forming Bacilli isolated
13. Brunzell J. Hypertriglyceridemia. N Eng J Med. 2007;357:1009-17. from the human gastrointestinal tract. J. Appl. Microbiol 2008; 105 2178–2186.

26 Integrative Medicine • Vol. 19, No. 2 • April 2020 Campbell—Spore Forming Bacilli Supplementation for HT